Prescott Group Capital Management L.L.C. held its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,600 shares of the company’s stock at the end of the second quarter. Prescott Group Capital Management L.L.C.’s holdings in Henry Schein were worth $476,000 as of its most recent SEC filing.
A number of other large investors have also made changes to their positions in the company. SpiderRock Advisors LLC acquired a new stake in shares of Henry Schein during the first quarter worth $102,000. Westside Investment Management Inc. acquired a new stake in shares of Henry Schein during the first quarter worth $168,000. JNBA Financial Advisors acquired a new stake in shares of Henry Schein during the first quarter worth $170,000. Peddock Capital Advisors LLC boosted its stake in shares of Henry Schein by 29.1% in the first quarter. Peddock Capital Advisors LLC now owns 1,097 shares of the company’s stock worth $186,000 after buying an additional 247 shares during the period. Finally, Van ECK Associates Corp boosted its stake in shares of Henry Schein by 5.7% in the first quarter. Van ECK Associates Corp now owns 1,138 shares of the company’s stock worth $193,000 after buying an additional 61 shares during the period. Institutional investors and hedge funds own 90.60% of the company’s stock.
Henry Schein, Inc. (HSIC) traded down 0.07% during midday trading on Friday, hitting $169.49. 525,408 shares of the stock were exchanged. The company has a market cap of $13.40 billion, a PE ratio of 24.77 and a beta of 1.09. The firm’s 50 day moving average price is $179.49 and its 200 day moving average price is $175.49. Henry Schein, Inc. has a 12 month low of $146.23 and a 12 month high of $186.99. Henry Schein’s stock is scheduled to split before the market opens on Friday, September 15th. The 2-1 split was announced on Wednesday, August 16th. The newly issued shares will be distributed to shareholders after the market closes on Thursday, September 14th.
Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, August 8th. The company reported $1.75 EPS for the quarter, beating the consensus estimate of $1.73 by $0.02. Henry Schein had a net margin of 4.59% and a return on equity of 19.91%. The business had revenue of $3.06 billion during the quarter, compared to analysts’ expectations of $3.05 billion. During the same period in the previous year, the business posted $1.64 EPS. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. On average, equities research analysts forecast that Henry Schein, Inc. will post $7.27 earnings per share for the current fiscal year.
WARNING: This article was reported by BNB Daily and is owned by of BNB Daily. If you are accessing this article on another domain, it was illegally stolen and republished in violation of United States and international trademark and copyright laws. The original version of this article can be accessed at https://www.baseball-news-blog.com/2017/08/19/prescott-group-capital-management-l-l-c-has-476000-position-in-henry-schein-inc-hsic-updated-updated-updated.html.
HSIC has been the topic of a number of recent research reports. Zacks Investment Research upgraded shares of Henry Schein from a “hold” rating to a “buy” rating and set a $206.00 price objective on the stock in a report on Friday, June 16th. Northcoast Research upgraded shares of Henry Schein from a “neutral” rating to a “buy” rating and set a $218.00 price objective on the stock in a report on Monday, August 7th. Credit Suisse Group restated a “hold” rating and issued a $160.00 price objective on shares of Henry Schein in a report on Thursday, July 13th. Finally, Stifel Nicolaus restated a “hold” rating on shares of Henry Schein in a report on Thursday, July 6th. One analyst has rated the stock with a sell rating, ten have assigned a hold rating and seven have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and an average target price of $185.56.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.